Lb Pharmaceuticals Inc share price logo

Lb Pharmaceuticals Inc Share Price

NASDAQ: LBRX

Small Cap

$16.11

-0.09

(-0.56%)

Live

as on

Lb Pharmaceuticals Inc Stock Performance

as on November 7, 2025 at 12:37 am IST

  • Day's Low

    Day's High

    $15.74
    $16.56
    downward going graph

    2.30%

    Downside

    2.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.36
    $20.25
    downward going graph

    17.07%

    Downside

    25.70%

    Upside

    downward going graph

Lb Pharmaceuticals Inc share price movements today

Previous Close
$16.20
Open
$16.46
Volume
146.6K
Day's Low - High
$15.74 - $16.56
52 Week Low - High
$13.36 - $20.25

Lb Pharmaceuticals Inc Historical Returns

1 Month Return
+ 7 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Lb Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Lb Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Lb Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Lb Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Lb Pharmaceuticals Inc image
Lb Pharmaceuticals Inc
NA$-NANA0.00%

Lb Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Lb Pharmaceuticals Inc Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Lb Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-16
-26
EBITDA
-16
-27
Interest Expense
-
-
Depreciation
0
0
Income Before Tax
-16
-27
Income Tax Expense
-
-
Net Income
-16
-27
Net Profit Margin
0.00%
0.00%

Lb Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
Gross Profit
-
-
-
Operating Income
-2
-11
-64
EBITDA
-12
-1
-63
Interest Expense
2
4
-
Depreciation
0
0
0
Income Before Tax
-14
-6
-63
Income Tax Expense
0
0
0
Net Income
-14
-6
-63
Net Profit Margin
0.00%
0.00%
0.00%

Lb Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Net Income
-27
Operating Cash Flow
-15
Investing Cash Flow
6
Financing Cash Flow
0
Change in Cash
-8

Lb Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Net Income
-6
-63
Operating Cash Flow
-12
-53
Investing Cash Flow
-28
23
Financing Cash Flow
33
38
Change in Cash
-6
8

Insights on Lb Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, LBRX stock has moved up by 7.0%

About Lb Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.
OrganisationLb Pharmaceuticals Inc
HeadquartersOne Pennsylvania Plaza, New York, NY, United States, 10119
CEOMs. Heather D. Turner J.D.
E-voting on sharesClick here to vote

Key Management of Lb Pharmaceuticals Inc

Name

Title

Mr. Marc L. Panoff CPA

Senior Vice President of Finance

Mr. Gad Soffer

Chief Business Officer

Dr. Richard Silva Ph.D.

Senior Vice President of Technical Operations

Dr. James Rawls Pharm.D.

Senior Vice President of Regulatory Affairs

Ms. Heather D. Turner J.D.

CEO & Director

Mr. Zachary Prensky

Co-founder, Advisor to the CEO & Director

Dr. Anna Eramo M.D.

Chief Medical Officer

FAQs

What is Lb Pharmaceuticals Inc share price today?

Lb Pharmaceuticals Inc share price today is $16.11 as on . Lb Pharmaceuticals Inc share today touched a day high of $16.56 and a low of $15.74.

What is the 52 week high and 52 week low for Lb Pharmaceuticals Inc share?

Lb Pharmaceuticals Inc share touched a 52 week high of $20.25 on and a 52 week low of $13.36 on . Lb Pharmaceuticals Inc stock price today i.e. is trending at $16.11,which is 20.44% down from its 52 week high and 20.58% up from its 52 week low.

How to invest in Lb Pharmaceuticals Inc Stock (LBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lb Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lb Pharmaceuticals Inc Shares that will get you 0.0931 shares as per Lb Pharmaceuticals Inc share price of $16.11 per share as on November 7, 2025 at 12:37 am IST.

What is the minimum amount required to buy Lb Pharmaceuticals Inc Stock (LBRX) from India?

Indian investors can start investing in Lb Pharmaceuticals Inc (LBRX) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Lb Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Lb Pharmaceuticals Inc share’s latest price of $16.11 as on November 7, 2025 at 12:37 am IST, you will get 0.6207 shares of Lb Pharmaceuticals Inc. Learn more about fractional shares .